Literature DB >> 2343691

Fine needle aspiration cytology in a case of diffuse sclerosing carcinoma of the thyroid.

G Caruso1, B Tabarri, I Lucchi, V Tison.   

Abstract

The fine needle aspiration (FNA) cytologic findings in a rare case of bilateral diffuse sclerosing carcinoma of the thyroid are described. Along with a generally papillary architecture, the FNA biopsy smears showed a number of features not usually seen in thyroid carcinomas: psammoma bodies, an abundance of squamous metaplasia and a dense inflammatory component. The FNA diagnosis was multifocal papillary carcinoma with squamous metaplasia; histopathologic examination made the final diagnosis.

Entities:  

Mesh:

Year:  1990        PMID: 2343691

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  5 in total

1.  Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.

Authors:  Lester D R Thompson; Jacqueline A Wieneke; Clara S Heffess
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis.

Authors:  Eric J Kuo; Paolo Goffredo; Julie A Sosa; Sanziana A Roman
Journal:  Thyroid       Date:  2013-09-14       Impact factor: 6.568

3.  Fine-needle aspiration of the thyroid: an overview.

Authors:  Gia-Khanh Nguyen; Mark W Lee; Jody Ginsberg; Tina Wragg; Darcy Bilodeau
Journal:  Cytojournal       Date:  2005-06-29       Impact factor: 2.091

Review 4.  Circulating thyroid stimulating hormone receptor messenger RNA and differentiated thyroid cancer: A diagnostic meta-analysis.

Authors:  Zhen-Zhen Zhang; Qiang Chen; Chao-Yue Kong; Zhan-Ming Li; Li-Shun Wang
Journal:  Oncotarget       Date:  2017-01-24

5.  Stromal tissue as an adjunct tool in the diagnosis of follicular thyroid lesions by fine-needle aspiration biopsy.

Authors:  Kien T Mai; Kevin Hogan
Journal:  Cytojournal       Date:  2016-08-31       Impact factor: 2.091

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.